vidarabine has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brannagan, TH; Leitch, MM; Sherman, WH | 2 |
2 other study(ies) available for vidarabine and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Fludarabine in the Treatment of Refractory Chronic Inflammatory Demyelinating Neuropathies.
Topics: Aged; Antineoplastic Agents; Cyclophosphamide; Female; Humans; Immunoglobulin M; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myelin-Associated Glycoprotein; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies; Severity of Illness Index; Vidarabine | 2015 |
Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
Topics: Cyclophosphamide; Disease Progression; Female; Humans; Immunosuppressive Agents; Middle Aged; Neural Conduction; Peripheral Nerves; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome; Vidarabine | 2013 |